3-Cyano-4-Isobutoxybenzothioamide Coa Pharma Grade High Purity Supply Chain Analysis
- [Thioamide Stability]: Optimized storage protocols prevent degradation of the cyano group during transit.
- [Batch Scalability]: Production lines configured for kilogram to tonne quantities without yield loss.
- [Audit Readiness]: Full documentation packages including COA and SDS available for immediate review.
In the competitive landscape of pharmaceutical intermediates, securing a reliable supply of 3-Cyano-4-isobutoxybenzothioamide (CAS: 163597-57-7) is critical for the uninterrupted production of Febuxostat. This key building block requires stringent control over reaction parameters to ensure industrial purity levels meet global regulatory standards. As demand for gout therapeutics rises, procurement teams must prioritize suppliers who can demonstrate consistent batch-to-batch consistency and robust quality assurance systems.
Optimizing the Synthesis Route for Maximum Yield
For process chemists and R&D directors, the primary challenge lies in the thioamide formation step. The conversion of the corresponding nitrile or amide precursor requires precise temperature control to minimize side reactions that could compromise the Febuxostat intermediate profile. Our manufacturing process utilizes advanced catalytic systems to enhance conversion rates while suppressing impurities such as unreacted starting materials or over-thionated byproducts.
Achieving pharma grade status necessitates rigorous purification steps, often involving recrystallization or column chromatography depending on the scale. When evaluating potential partners, technical teams should request detailed impurity profiles alongside standard certificates. Understanding the specific synthesis route employed by your manufacturer allows for better prediction of potential genotoxic impurities and ensures smoother regulatory filings downstream.
Commercial Viability and Bulk Procurement Strategies
Procurement officers face the dual challenge of securing competitive bulk price points while maintaining supply chain resilience. Market volatility can impact the availability of raw materials required for organic synthesis, making it essential to partner with a global manufacturer capable of buffering these fluctuations. We offer flexible packaging specifications, ranging from 1kg samples for lab testing to 25kg drums for pilot plants and commercial production.
When sourcing high-purity C12H14N2OS, buyers should verify the supplier's capacity to handle custom synthesis requests if standard specifications do not meet specific project needs. A reliable chemical supplier will provide transparent communication regarding lead times and inventory levels, ensuring that production schedules are not disrupted by logistical bottlenecks.
Technical Specifications and Quality Parameters
To facilitate quick evaluation by quality control teams, the following table outlines the standard technical specifications for this intermediate. These parameters are strictly enforced to ensure compatibility with downstream pharmaceutical applications.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 163597-57-7 | N/A |
| Molecular Formula | C12H14N2OS | Elemental Analysis |
| Molecular Weight | 234.32 g/mol | Calculated |
| Purity (HPLC) | ≥ 98.0% | Area Normalization |
| Appearance | Off-white to Light Yellow Solid | Visual Inspection |
| Packaging | 1kg, 5kg, 25kg (Aluminum Foil/Drum) | N/A |
Regulatory Compliance and Manufacturer Credibility
For executives overseeing strategic sourcing, regulatory compliance is non-negotiable. Facilities must adhere to strict environmental and safety standards, ensuring that all outputs are suitable for integration into regulated drug products. NINGBO INNO PHARMCHEM CO.,LTD. operates as a premier global manufacturer offering these technical advantages and bulk supply capabilities, ensuring that every shipment is accompanied by a comprehensive COA verification package.
Scalability is another critical factor for commercial viability. The ability to ramp up production from kilogram to tonne quantities without altering the quality profile demonstrates process robustness. Partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. provides the assurance of long-term supply stability, mitigating risks associated with single-source dependencies in the complex pharmaceutical supply chain.
To proceed with sampling or to discuss large-scale procurement requirements, please contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote.